Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

11 juin 2024 04h00 HE | Source: AKAMPION

Thermosome Appoints Dr. Sabine Hauck as Chief Technical Officer

- Experienced biopharma professional focused on drug product development Munich, Germany - June 11, 2024 - Thermosome, a drug development company focused on targeted tumor therapies, today...
06 févr. 2024 04h00 HE | Source: AKAMPION

Thermosome Announces Further Dose Escalation in Phase I Trial with Lead Program THE001

- First dose level rated as safe by independent Data Safety Monitoring Board- Second dose level to be administered according to plan- THE001 designed as targeted tumor treatment independent...
24 mai 2023 04h00 HE | Source: AKAMPION

Thermosome Announces First Patient Dosed in Phase I Trial with Lead Program THE001

- Addressing high unmet medical need in locally advanced soft tissue sarcoma- Targeted tumor treatment independent of specific molecular targets or tumor subtypes Munich, Germany – May 24,...